Skip to main content

CNC

Stock

CNC

Stock
Health Care
Healthcare Plans

Performance overview

CNC Price
Price Chart

Forward-looking statistics

Beta
0.75
Risk
32.42%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Company info

SectorHealth Care
IndustryHealthcare Plans
Employees45K
Market cap$37.3B

Fundamentals

Enterprise value$28.1B
Revenue$153.3B
Revenue per employee
Profit margin2.25%
Debt to equity65.38

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$6.78
Dividend per share
Revenue per share$299.31
Avg trading volume (30 day)$276M
Avg trading volume (10 day)$563M
Put-call ratio

Macro factor sensitivity

Growth+1.1
Credit+2.2
Liquidity+0.3
Inflation-2.1
Commodities-0.1
Interest Rates-0.8

Valuation

Dividend yield0.00%
PEG Ratio4.73
Price to sales0.11
P/E Ratio4.73
Enterprise Value to Revenue0.18
Price to book0.59

Upcoming events

Next earnings dayApril 25, 2025
Next dividend day
Ex. dividend day

News

Centene Stock Down 40% — May Slide On $1 Trillion Medicaid Cuts

The Big Beautiful Bill Act cuts $1 trillion from Medicaid from which Centene gets 58% of its revenue. After plunging 40% will the stock drop more?

Forbes (July 9, 2025)
Jim Cramer on what is behind Centene's 40% drop

'Mad Money' host Jim Cramer dissects Centene's massive plummet following earnings.

CNBC Television (July 3, 2025)
Jim Cramer gives his take on Centene's decline and the managed care sector

CNBC's Jim Cramer offered his take on Centene and the broader health insurance space as its stock plummeted when management unexpectedly withdrew full-year guidance. "Given this news from Centene, I think the whole managed care industry is borderline un-investable right now," he said.

CNBC (July 2, 2025)
Is Centene (CNC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research (July 2, 2025)
Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.

Benzinga (July 2, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free